Literature DB >> 2661800

Primary fetal hydrothorax: natural history and management.

M T Longaker1, J M Laberge, J Dansereau, J C Langer, T M Crombleholme, P W Callen, M S Golbus, M R Harrison.   

Abstract

Primary fetal hydrothorax presents a wide spectrum of severity ranging from small, harmless effusions, to life-threatening thoracic compression. To define natural history and management, we reviewed 32 cases seen at two large perinatal centers from 1980 to 1987. Spontaneous resolution of the effusions was seen in three fetuses, all of whom survived. Three fetuses were electively terminated. The overall mortality was 53%. In the 24 untreated fetuses, sex and the presence of polyhydramnios did not influence mortality, but hydrops, gestational age less than 35 weeks at delivery, and bilateral effusions were associated with a poor prognosis. Five fetuses underwent in utero decompression. In four, thoracentesis was performed, with rapid reaccumulation of the effusion. All four died from pulmonary insufficiency. In the fifth fetus, a thoracoamniotic shunt permanently decompressed the effusion, with resolution of the hydrops, and delivery of a normal viable infant. We conclude that (1) primary fetal hydrothorax may resolve or progress to hydrops, necessitating close follow-up with ultrasound; (2) pulmonary hypoplasia as a result of undrained large pleural effusions may result in neonatal mortality; (3) the gestational age at both diagnosis and delivery, the development of hydrops, and bilaterality of effusions are important prognostic predictors; and (4) the fetus with large effusions and hydrops has a poor prognosis, and thoracic decompression with a thoracoamniotic shunt may prove life saving.

Entities:  

Mesh:

Year:  1989        PMID: 2661800     DOI: 10.1016/s0022-3468(89)80509-3

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  The neural and vascular effects of killed Su-Streptococcus pyogenes (OK-432) in preterm fetal sheep.

Authors:  L Bennet; R V Cowie; P R Stone; R Barrett; A S Naylor; A B Blood; A J Gunn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-19       Impact factor: 3.619

Review 2.  Current status of management of neonatal chylothorax.

Authors:  A L al-Arfaj; P Upadhyaya; K al-Umran
Journal:  Indian J Pediatr       Date:  1992 Jan-Feb       Impact factor: 1.967

3.  Isolated bilateral severe fetal hydrothorax: complete resolution following a single postnatal thoracocentesis.

Authors:  Bhat Y Ramesh; Naveen Kumar
Journal:  Indian J Pediatr       Date:  2011-06-25       Impact factor: 1.967

Review 4.  Fetal pleural effusion and Down syndrome.

Authors:  Li Cao; Yan Du; Ling Wang
Journal:  Intractable Rare Dis Res       Date:  2017-08

Review 5.  Management of the fetus with a cystic adenomatoid malformation.

Authors:  N S Adzick; M R Harrison
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

6.  The fetus as a patient. Surgical considerations.

Authors:  M R Harrison; N S Adzick
Journal:  Ann Surg       Date:  1991-04       Impact factor: 12.969

7.  Nonchylous idiopathic pleural effusion in the newborn.

Authors:  Geeta Gathwala; Jagjit Singh; K N Rattan; Kapil Bhalla
Journal:  Indian J Crit Care Med       Date:  2011-01

8.  Fetal primary hydrothorax with spontaneous resolution.

Authors:  Vera Trocado; J P Coutinho-Borges; Mariana Carlos-Alves; Joaquim Santos; Paula Pinheiro
Journal:  Case Rep Womens Health       Date:  2017-06-10

9.  Intrauterine Thoracoamniotic Shunting of Fetal Hydrothorax with the Somatex Intrauterine Shunt: Intrauterine Course and Postnatal Outcome.

Authors:  Joleen Grandt; Ingo Gottschalk; Annegret Geipel; Ulrich Gembruch; Corinna Simonini; Eva Weber; Christoph Berg; Andreas Müller; Brigitte Strizek
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.241

Review 10.  Fetal therapies as standard prenatal care in Japan.

Authors:  Haruhiko Sago; Seiji Wada
Journal:  Obstet Gynecol Sci       Date:  2020-02-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.